168 related articles for article (PubMed ID: 24863090)
1. Exercise is associated with better quality of life in patients on TSH-suppressive therapy with levothyroxine for differentiated thyroid carcinoma.
Vigário Pdos S; Chachamovitz DS; Teixeira Pde F; Rocque Mde L; Santos ML; Vaisman M
Arq Bras Endocrinol Metabol; 2014 Apr; 58(3):274-81. PubMed ID: 24863090
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomized controlled trial.
Eustatia-Rutten CF; Corssmit EP; Pereira AM; Frölich M; Bax JJ; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2006 Mar; 64(3):284-91. PubMed ID: 16487438
[TBL] [Abstract][Full Text] [Related]
3. Quality of life, muscle strength, and fatigue perception in patients on suppressive therapy with levothyroxine for differentiated thyroid carcinoma.
de Oliveira Chachamovitz DS; dos Santos Vigário P; Nogueira Cordeiro MF; de Castro CL; Vaisman M; dos Santos Teixeira Pde F
Am J Clin Oncol; 2013 Aug; 36(4):354-61. PubMed ID: 22643561
[TBL] [Abstract][Full Text] [Related]
4. Exercise training improves quality of life in women with subclinical hypothyroidism: a randomized clinical trial.
Werneck FZ; Coelho EF; Almas SP; Garcia MMDN; Bonfante HLM; Lima JRP; Vigário PDS; Mainenti MRM; Teixeira PFDS; Vaisman M
Arch Endocrinol Metab; 2018 Oct; 62(5):530-536. PubMed ID: 30462806
[TBL] [Abstract][Full Text] [Related]
5. Effects of physical activity on body composition and fatigue perception in patients on thyrotropin-suppressive therapy for differentiated thyroid carcinoma.
Vigário Pdos S; Chachamovitz DS; Cordeiro MF; Teixeira Pde F; de Castro CL; de Oliveira FP; Vaisman M
Thyroid; 2011 Jul; 21(7):695-700. PubMed ID: 21615309
[TBL] [Abstract][Full Text] [Related]
6. The effect of long-term thyroid-stimulating hormone suppressive therapy on the cognitive function of elderly patients with differentiated thyroid carcinoma.
Moon JH; Ahn S; Seo J; Han JW; Kim KM; Choi SH; Lim S; Park YJ; Park DJ; Kim KW; Jang HC
J Clin Endocrinol Metab; 2014 Oct; 99(10):3782-9. PubMed ID: 25029415
[TBL] [Abstract][Full Text] [Related]
7. Effects of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with thyroid cancer.
Mousavi Z; Dourandish L; Rokni H; Sadeghi R; Rasoul Zakavi S
Minerva Endocrinol; 2014 Mar; 39(1):59-65. PubMed ID: 24513605
[TBL] [Abstract][Full Text] [Related]
8. Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy.
Crevenna R; Zettinig G; Keilani M; Posch M; Schmidinger M; Pirich C; Nuhr M; Wolzt M; Quittan M; Fialka-Moser V; Dudczak R
Support Care Cancer; 2003 Sep; 11(9):597-603. PubMed ID: 12783288
[TBL] [Abstract][Full Text] [Related]
9. The effect of iatrogenic subclinical hyperthyroidism on anxiety, depression and quality of life in differentiated thyroid carcinoma.
Gülsoy Kirnap N; Turhan Iyidir Ö; Bozkuş Y; Işildak ŞM; Anil C; Firat SN; Demir C; Nar A; Başçil Tütüncü N
Turk J Med Sci; 2020 Jun; 50(4):870-876. PubMed ID: 32490648
[TBL] [Abstract][Full Text] [Related]
10. Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring.
Mercuro G; Panzuto MG; Bina A; Leo M; Cabula R; Petrini L; Pigliaru F; Mariotti S
J Clin Endocrinol Metab; 2000 Jan; 85(1):159-64. PubMed ID: 10634380
[TBL] [Abstract][Full Text] [Related]
11. Impaired functional and hemodynamic response to graded exercise testing and its recovery in patients with subclinical hyperthyroidism.
Vigário Pdos S; Chachamovitz DS; Teixeira Pde F; Santos MA; Oliveira FP; Vaisman M
Arq Bras Endocrinol Metabol; 2011 Apr; 55(3):203-12. PubMed ID: 21655869
[TBL] [Abstract][Full Text] [Related]
12. Early detection of isolated left ventricular diastolic dysfunction in high-risk differentiated thyroid carcinoma patients on TSH-suppressive therapy.
Taillard V; Sardinoux M; Oudot C; Fesler P; Rugale C; Raingeard I; Renard E; Ribstein J; du Cailar G
Clin Endocrinol (Oxf); 2011 Nov; 75(5):709-14. PubMed ID: 21645022
[TBL] [Abstract][Full Text] [Related]
13. Naming difficulties after thyroid stimulating hormone suppression therapy in patients with differentiated thyroid carcinoma: a prospective cohort study.
Jin S; Yang YT; Bao W; Bai Y; Ai JW; Liu Y; Yong H
Endocrine; 2019 Aug; 65(2):327-337. PubMed ID: 31056722
[TBL] [Abstract][Full Text] [Related]
14. Glucose tolerance and lipid profile in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomised controlled trial.
Heemstra KA; Smit JW; Eustatia-Rutten CF; Heijboer AC; Frölich M; Romijn JA; Corssmit EP
Clin Endocrinol (Oxf); 2006 Dec; 65(6):737-44. PubMed ID: 17121524
[TBL] [Abstract][Full Text] [Related]
15. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer.
Biondi B; Cooper DS
Thyroid; 2010 Feb; 20(2):135-46. PubMed ID: 20151821
[TBL] [Abstract][Full Text] [Related]
16. Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma.
Botella-Carretero JI; Galán JM; Caballero C; Sancho J; Escobar-Morreale HF
Endocr Relat Cancer; 2003 Dec; 10(4):601-10. PubMed ID: 14713270
[TBL] [Abstract][Full Text] [Related]
17. [Clinical endocrinologists' perception of the deleterious effects of TSH suppressive therapy in patients with differentiated thyroid carcinoma].
Reverter JL; Colomé E; Puig Domingo M; Julián T; Halperin I; Sanmartí A
Endocrinol Nutr; 2010 Oct; 57(8):350-6. PubMed ID: 20494634
[TBL] [Abstract][Full Text] [Related]
18. No Effect of the Thr92Ala Polymorphism of Deiodinase-2 on Thyroid Hormone Parameters, Health-Related Quality of Life, and Cognitive Functioning in a Large Population-Based Cohort Study.
Wouters HJ; van Loon HC; van der Klauw MM; Elderson MF; Slagter SN; Kobold AM; Kema IP; Links TP; van Vliet-Ostaptchouk JV; Wolffenbuttel BH
Thyroid; 2017 Feb; 27(2):147-155. PubMed ID: 27786042
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality-of-life study in patients with carcinoma of the thyroid after thyroxine withdrawal for whole body scanning.
Chow SM; Au KH; Choy TS; Lee SH; Yeung NY; Leung A; Leung A; Leung HL; Shek CC; Law SC
Laryngoscope; 2006 Nov; 116(11):2060-6. PubMed ID: 17075410
[TBL] [Abstract][Full Text] [Related]
20. Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer.
Santoro AB; Vargens DD; Barros Filho Mde C; Bulzico DA; Kowalski LP; Meirelles RM; Paula DP; Neves RR; Pessoa CN; Struchine CJ; Suarez-Kurtz G
Br J Clin Pharmacol; 2014 Nov; 78(5):1067-75. PubMed ID: 24910925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
